endovision - medica · • establishes endovision global (hong kong) ... • mfds : class 1(5...

Infinite vision of the medical device Innovation makes differentiation

ENDOVISION

ⓒ ENDOVISION Co., Ltd. All Right Reserved.

ENDOVISION SINCE 2011

2018 • Completes FDA Establishment Registration : 19 products • Obtains CE Mark Certificate : CoC (8 products), DoC (9 products) • MFDS : 8 products are registered; 6 products are certified; and 4

products are approved

2017 • Signs an investment agreement with Jeil Pharmaceutical Co., Ltd. • Establishes Endovision Global (Hong Kong) • Obtains ISO13485 Certificate • Completes FDA Establishment Registration • Obtains CE Mark Certificate : DoC (17 products) • MFDS : class 1(5 products), class 2(3 products), class 3-4(1 product)

2016 • Files a patent application for the fixing device for a medical device

placed in the gastrointestinal tract, etc. • Camera-still-surgical & Light source-general-purpose are approved by

the Ministry of Food and Drug Safety

2019 • Establishes R&D Center in Daegu-Gyeongbuk Medical Cluster • Kyungpook National University 3D Printing Medical Device (implants for

spine) technology transfer and manufacturing business agreement signed

2015 • Is selected as Pre-Star Enterprise • Dressing-topical hemostasis-extermal is approved by the Ministry of

Food and Drug Safety • Obtains a patent for incontinence prevention device for men • UBE-Probe is approved by MFDS • Flexcat-R is approved by MFDS

2014 • Establishes the corporate affiliated research center • Obtains KGMP certification • EN-UBE Instrument set (UBE Tool Kit) is approved by MFDS • Obtains a patent for recovery device after cervical surgery, etc.

2013 • Certified as a venture company

2011 • Establishes Endovision


We Are ‘ENDOVISION’

'ENDOVISION' is used to research, development, and manufacture advanced medical technologies by participating with current doctors and medical device experts in Korea with the goal of localization of medical devices

Exploring and researching

Ideas with domestic medical staff

Continuing the advancement

of our technology

• Securing intellectual property rights domestic and abroad.

• Technology Transfer for product commercialization.

• Securing transfer of technology against revenue from sales.

• Securing Korean medical devices technology. • Technology fusion and complex through the

cooperation of professional manufacturers. • Outstanding technology transfer to abroad.

Development

• Securing core technologies. • Creating a professional infrastructure. • Building quality management system.

Production


Research

Major Members

It is composed of doctors specializing in various fields of medical care with CEO, Min-ho Jung who has been leading major research in Korea's major drug developers

CEO

Sang-kyu Son -

• Neurosurgery specialist

(doctor) at Kyungpook

national university hospital

• Director, center for

Vertebrae Center,

Gangdong hospital, Gumi

• Neurosurgery director

Park won wook hospital,

Busan

• UBE developers

Technical adviser

Jae-hwang Kim -

• Department of surgery,

Kyungpook national

university hospital (Doctor)

• Professor of general

surgery, Yeungnam

university hospital

• Director, robot surgery

Center, Yeungnam

university hospital

• FDD developer

Dae-ki Hong -

• Kyungpook national

university hospital

gynecologist (doctor)

• Professor , Chilgok

kyungpook national

university hospital

• Gynecological products

developer

Dong-wan Kang -

• Busan Wellness Hospital

(Hospital Director)

• The ward chief,

christian hospital ,

Germany

• Ambulatory Professor Inje

university Baek Hospital

• BANANA-Clip developer


• Graduate school of

pharmacy, Yeungnam

university (Master)

• Researcher, Dongwha

chemical central research

institute

• Head of marketing, Boston

scientific

• Director, FineMedix

development Co., Ltd

Technical adviser Technical adviser

Min-ho Jung -

Technical adviser

Technical adviser

Our Business Area


ENDOVISION

SPINE ENDOVISION

BIO ENDOVISION

CONSUMABLE ENDOVISION

R&D

The first

in the worldENDOVISION SPINE

The ENDOVISION, which holds intellectual property rights to the “UBE(Unilateral Bi-portal Endoscopy) and surgical tools," creates the safest and most sophisticated products.

MFDS & CE

MFDS and CE Products

About 100 Domestic hospitals

Negotiating progress with about 100 domestic hospitals

Technical Transfer Request

Requests for technical transfer from specialists In the

U.S, Malaysia, Taiwan, etc.


Open Surgery

* Comparison between traditional surgery and UBE

UBE Tool kit Plus ENDOSPINE RF console

UBE pro probe TRAUS

UBE scope kit UBE Diamond burr

One-portal Endoscopic Surgery

UBE(Unilateral Biportal Endoscopy)

The first

in the worldENDOVISION BIO

HR-Chitosan, a technology of ENDOVISION is effective in all aspects: moisturizing

nti-microbial / deodorization

MFDS & CE

MFDS and CE Products

Ministry of National

Defense supply

2016/2017 Supply to military

JEIL pharmaceutical


Hemostatic agent Hemostatic dressing

* Comparison between traditional hemostatic agent and ENDOVISION hemostatic dressing

moisturizing nti-microbial / deodorization

JEIL pharmaceutical Exclusive distributor

NEXOSEAL V (Semi gelation)

DUAL LAPARO V DUAL PATTY V

DUAL TULIP V DUAL STOP V

NEXOSEAL V (Full gelation)

The first

in the worldENDOVISION CONSUMABLE

ENDOVISION CONSUMABLE products are excellent in safety and efficiency and consider about maximized for user convenience by ease operation.

Localization

100% Localization success Of dependence on

imported goods

GEMSKOREA Exclusive

distributor

Cooperate with GEMSKOREA

B.BRAUN

Cooperate with B.BRAUN (Global medical device company)

for overseas market. ⓒ ENDOVISION Co., Ltd. All Right Reserved.

Chinese products

* Comparison between Endovision 'Clear Port' and Chinese products

SEN Disposable

Biopsy Forceps

SEN Injection Needle

SEN Polypectomy

Snare

BANANA-Clip EN-Clip

Clear Port + NEO filter

ENDOVISION 'Clear Port'

The first

in the worldENDOVISION R&D

ENDOVISION is not satisfied with today's products, it studies and develops innovative products with amazing ideas and technology.

CE

Patent approval

Patent certification, such as cervical anti-adhesion device

New Market Pioneer

Entering new market by developing new item


Brand name Features

Securing passageways in the cervix, excretion of

secretions and anti-adhesion of the affected area

Partially compressible urinary incontinence

clamp unlike other products

Characterized by the shape of a brush, for

excellent obtaining samples

Optimized for cervical tissue and cervical cancer

characteristics

Excellent hydrogel for hemostatic, anti-microbial,

wet environment, and tissue regeneration

Superior bleeding management due to high

effluent absorption, creating wet environment

to help regenerate tissue (Powder/Sponge)

and progress of CE certificate

EN-Sealer

CerviQ Biopsy needle CerviQ pipel

HEMO sugar / NEXOSEN

KITO activator

Con-Cap

Expanding the market by continuously developing new products

Exploring a unique area in the field of domestic medical devices

Continuous research and development based on professional technology

Patent Description Patent Description Technical Assurance

Fund A + members

selected

Medical Device Manufacturing

Permission complete

Achievement

Acquired domestic and foreign intellectual property rights for 18 original technologies and products


Surgical device set for performing minimally invasive of endoscopic spinal surgery

Recovery device after cervical surgery

Device for prevention of male urinary incontinence

Cannula

Surgical clip for ligation, and a clip applier for operating of the clip

Hemostatic dressing material and manufacturing method based on chitosan

Fixation device for Intestinal instruments

Manufacturing equipment of Bundled optical fiber probe

Applier for providing hemostatic clip

Material injector set of nerve block for pain control

Artificial intestine management device

Device for prevention of male urinary incontinence

Cross-section processing device of optic fiber

Device for prevention of cervical adhesion

Laser therapeutic feedback system

Device for lesion tissue collection

Device for airway retention

Device for plasma generation

Achievement

Recognized as an excellent technical skills by national organizations, Hosted a total of 12 research and development projects including ATC government-sponsored projects


Total expenses

Daegu-Gyeongbuk Medical Innovation Foundation

Ministry of Trade, Industry and Energy



Korea Health Industry Development Institute

Daegu Technopark

Ministry of Science , ICT and Future Planning

Korea Institute for Advancement of Technology

Ministry of SMEs and Startups




Estimated sales


Product

ENDOVISION SPINE

ENDOVISION BIO

ENDOVISION CONSUMABLE

ENDOVISION R&D

Licensing & Royalty

TOTAL

2020 2021

3.0

2.0

3.0

0.5

0.5

9.0

5.0

5.0

5.0

1.5

1.0

17.5

8.0

8.0

7.0

3.0

2.0

28

(Unit : Million $)

01 02 03 04

Action Plan


Early stage of start-up

• Optimization of Production System for Developed Products

• Acquiring domestic and international certificates and permits

• Finding domestic Partnerships

• Securing intellectual property rights

Currently in progress

• Finding partners for overseas cooperation

• UBE overseas market Launch

• Securing intellectual property overseas

• Establishment of overseas branches (U.S., Japan)

• Achieving its target sales $ 100 million per year

• Recombinant proteins, medical device markets

• Bio, mechanical professional plant. Establishment of possible sustained revenue models

step

Partnering with leading Korean medical device manufacturers

Establishment of a foreign corporation to enter the global medical device market

Infinite vision of the medical device Innovation makes differentiation

ENDOVISION

Get in touch


1118-1 Dongnae-dong, Dong-gu, Daegu, Ref. of Korea

endovision - medica · • establishes endovision global (hong kong) ... • mfds : class 1(5...

Documents